Shelling out nearly $16,000 for a 14-day course of medication is what to expect for the wholesale cost of Zurzuvae, the first oral treatment for postpartum depression, according to a Nov. 7 news release from drugmaker Sage Therapeutics.
Read the full post on Becker's Hospital Review - Healthcare News
